Richard Wright, MD

Learning objectives:

• Summarize the benefits of the Core Four Heart Failure drugs
• Discuss the impacts of diuretics, ivabradine, iron replacement, salt, digoxin, and devices for heart failure patients
• Improve medical management of heart failure patients

Learning objectives:

• Identify limitations of conventional approaches to HF management
• Summarize mechanisms of HF decompensation and methods for early detection
• Discuss clinical evidence for a wireless, pulmonary artery pressure sensor

• Listeners will be able to appropriately identify signs and symptoms of amyloid cardiomypathy
• Listeners will be able to appropriately approach the diagnotic pathways for amyloid cardiomypathy
• Listeners will be able to define the evolving role of the cardiologist in the treatment of ATTR cardiomypathy
• Listeners will be able to define the evolving role of the cardiologist in the treatment of AL cardiomypathy

Learning objective:

• Participants will provide better patient care through an enhanced ability to manage the increasing heart failure population presented by expert faculty

Learning objective:

• Describe the benefits afforded by referral of patients to an advanced heart failure program
• Describe barriers likely to underlie under-referral of eligible patients
• Summarize the value of team-based care and its importance in the management of patients with heart failure

Learning objectives:

• Discuss the current medical adherence to guideline directed medical therapy for heart failure patients
• Discuss the role of AI in medically managing heart failure patients
• Discuss the cost impact of heart failure patients

Learning objectives:

• Identify the criteria for the five stages of cardiogenic shock.
• Summarize the differences in findings between cardiogenic shock associated with acute myocardial infarction versus decompensated heart failure.
• Identify factors affecting the selection of mechanical circulatory support devices available for therapy of cardiogenic shock.

Learning objective:

• Summarize the current landscape of heart transplant
• Describe the evolution of durable MCS
• Review opportunities for expanding heart transplant and durable MCS

Learning objective:

• Participants will provide better patient care for their heart failure patients by discussing guideline directed medical therapy, medical management, artificial intelligence, and cardiogenic shock presented by expert faculty

• Discuss the effect of AF ablation on clinical outcomes in heart failure patients (both HFREF and HFPEF).
• Describe the impact of PVCs on ventricular function.
• Discuss the role of catheter ablation of scar-related VT in patients with ventricular dysfunction.

• Describe the most common forms of acute cardiovascular disease with SARS-CoV-2 infection
• Discuss the epidemiology and cardiovascular manifestations of long COVID
• Summarize how best to approach return to play following SARS-CoV-2 infection

• Define the five categories of pulmonary hypertension
• Describe diagnostics to differentiate cardiac, pulmonary and mixed disease based on echocardiography and hemodynamics
• Differentiate risk factors for low risk vs high risk pulmonary hypertension
• Discuss the multi-drug treatment classes for WHO group 1 pulmonary arterial hypertension

• Describe the potential complications of percutaneous coronary interventions
• Outline the available treatment modalities for management of coronary complications
• Explain the potential ramifications of coronary complications

• Define wearable technologies, as well as their composition and use.
• Explain the current use of wearable devices in the diagnosis and management of atrial fibrillation.
• Discuss the potential of wearable devices in filling care gaps in heart failure patients.

• Summarize the description and natural history of the different types and severity classification of tricuspid valve diseases
• Describe the different surgical options for specific types of tricuspid valvular disease
• Summarize the immediate and long-term outcomes of surgical therapies
• Outline the best guess for future therapies

Robert Adamson, MD

Learning Objectives:

• Discuss the treatment options for pulmonary embolism
• Describe the multidisciplinary approach to treating pulmonary embolism
• Recite current literature regarding PE

Learning Objectives:

• Review the history and development of leadless pacemaker devices
• Review the pivotal clinical trials on leadless pacemakers and discuss the current indications for the procedure
• Review the future directions and innovations in leadless pacing

Learning objectives:

• Discuss the potential role of renal denervation in the management of AF and VT.
• Define the potential role of transcatheter bariatric embolotherapy in weight reduction, and the derivative effect on Atrial Fibrillation.
• Describe the mechanism by which ablation of the greater splanchnic nerve may improve outcomes in heart failure.

Learning objectives:

• Recite indication for catheter ablation in patient with paroxysmal atrial fibrillation
• Describe options for treatment of paroxysmal atrial fibrillation
• List major complication of catheter ablation

Charles Athill, MD

Learning objectives:

• Describe the impact of sleep on health
• Define the latest treatments for sleep apnea
• Summarize the latest treatments for other sleep disorders including insomnia and parasomnias

Learning Objectives:

• Describe the role of high cholesterol in the pathogenesis of coronary events
• Discuss new guidelines for treatment of cholesterol
• Explain why guidelines for cholesterol therapy have become more stringent with the updated guidelines

Learning objectives:

• Discuss the commitments of Professionalism including: Professional competence, Honesty with patients, Patient confidentiality, Maintaining appropriate relations with patients, Improving quality of care, Improving access to care, a just distribution of limited finite resources, Scientific knowledge, Maintaining trust by managing COIs, and Professional responsibilities.
• Define, through the use of case scenarios, recommendations related to Navigating Conflicts, relationships with industry (RWIs) and Conflicts of Interests (COIs) in Teaching and Publications, Peer Review, Research Data, Technology, and Expert Testimony.
•  Summarize concerns surrounding professionalism and ethics covering: Diversity, Equity, Inclusion, and Belonging: Optimizing Cardiovascular Health Care, Research, and Education Through Equity and Respect and Eliminating Bias, Discrimination, Harassment, and Racism; Enhancing the Well-Being of Clinicians; Patient Autonomy, Privacy, and Social Justice in Health Care; and Modern Healthcare Delivery: Challenges Related to New Care Delivery Systems.

• 11:30-12:00 PM

Learning objectives:

• Summarize concept of lifetime management for bioprosthetic aortic valve replacement.
• Discuss controversy surrounding cerebral protection in TAVR
• List reasons why TAVR indications may shift in the future

Learning objectives:

• Summarize the present state-of-the-art in the context of the person with Type II Diabetes and new therapies that have cardiovascular benefit
• Explain the appropriate use of these drugs for clinical decision making in asymptomatic patients.
• List the different medications and the outcomes associated with each in the context of diabetes

• Summarize treatment options for aortic aneurysms
• Describe the benefits and limitations of endovascular treatment
• Describe the benefits and limitations of open repair for the treatment of aortic aneurysm

Learning objectives:

• Discuss the best course of therapy for patients undergoing left atrial appendage occlusion
• Discuss the benefits and limitations of Watchman and Amulet
• Discuss the expected future of the LAAO technology

• Discuss the treatment options for peripheral arterial disease
• Describe the benefits and limitations of using a scalpel approach to treat peripheral arterial disease
• Describe the benefits and limitations of using a catheter to treat peripheral arterial disease

CLI:  Unmet Needs and Unanswered Questions

BEST-CLI:  A Trial for the Ages

Learning Objectives

• Discuss treatment approaches for Chronic Limb Ischemia
• Discuss recent advancements in treatment for CLI
• Discuss the updated clinical evidence for Chronic Limb Ischemia

Matthew Menard, MD

Learning objectives:

• Summarize the etiology and approaches to diagnosis and therapeutic strategies of coronary micro vascular dysfunction (CMD)
• Apply investigation regarding guidelines improvement of CMD IN women (and men}.
• Assess the gender difference of female-pattern IHD and the opportunity to improve the adverse outcomes experienced by women.

• Describe the current indications for PFO closure
• Discuss the future of PFO closure indications and device therapies
• Discuss transcatheter cardiac implant closure for non-PFO/ASD indications

Learning objectives:

• Identify classic CV lesions of Kawasaki Disease
• Define risks of thrombosis and myocardial fibrosis as sequelae of Kawasaki Disease
• Discuss the latest theories regarding etiology of Kawasaki Disease

Jane Burns, MD

John Gordon, MD